On-Demand Webinar: Complex, 3D Screening for Cancer Immunotherapy

Screening for potential anti-cancer immunotherapies benefits from 3D platforms to detect complex, multi-cell and multi-step effects on the immune system. Watch this on-demand webinar to learn: Differences between 2D and 3D drug screening models How 3D cultures can mimic cancer cell-immune cell interactions How to maximize reproducibility in a 3D drug screening assay Who Should […]

Read More…

Likarda Chooses Science Exchange as the Primary Online Channel to Offer 3D Compound Screening and Assay Development Services to Scientists

proteomics

PALO ALTO, CA, February 28, 2018 – Science Exchange, the world’s leading platform for outsourced research and development (R&D) services, announced a partnership with Likarda to offer online access to its innovative 3D compound screening and assay development services to scientists around the globe. Likarda is a Kansas City-based contract research organization (CRO) and a […]

Read More…

Tech Q&A with Likarda, LLC

3D Drug Screening

Guru Singh, Director of Scientific Content, recently spoke with Dr. Lisa Stehno-Bittel, President and Founder of Likarda LLC, an exciting biotech service company on the Science Exchange network.     GS: Nice to meet you, Lisa! Why do clients come to Likarda? LSB: Likarda is the company you come to when your scientific questions require […]

Read More…

New on Science Exchange: VR Tech, Cancer Genetics, Stem Cell-based Organoids

futuristic

Chandreyee Das, Ph.D. | Senior Content Manager, Science Exchange | blog.scienceexchange.com Virtual Reality Software: Explore biology at nanoscale From “Fantastic Voyage” (1966) to “A Wind in the Door” (1973), fiction has adored the idea of exploring the body at cellular and molecular levels. Now, virtual reality (VR) software, combined with the computational power afforded by blockchain […]

Read More…